SK9649Y1 - Hydrogél na báze zosieťovaného hydroxyfenylového derivátu kyseliny hyalurónovej - Google Patents

Hydrogél na báze zosieťovaného hydroxyfenylového derivátu kyseliny hyalurónovej Download PDF

Info

Publication number
SK9649Y1
SK9649Y1 SK50027-2022U SK500272022U SK9649Y1 SK 9649 Y1 SK9649 Y1 SK 9649Y1 SK 500272022 U SK500272022 U SK 500272022U SK 9649 Y1 SK9649 Y1 SK 9649Y1
Authority
SK
Slovakia
Prior art keywords
solution
derivative
hydrogel
chs
hydrogels
Prior art date
Application number
SK50027-2022U
Other languages
English (en)
Slovak (sk)
Other versions
SK500272022U1 (sk
Inventor
Ing. Toropitsyn Evgeniy
PharmDr. Pravda Martin, PhD.
Ing. Kovářová Lenka
Ing. Bystroňová Julie
doc. RNDr. CSc. Velebný Vladimír
Original Assignee
Contipro A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Contipro A.S. filed Critical Contipro A.S.
Publication of SK500272022U1 publication Critical patent/SK500272022U1/sk
Publication of SK9649Y1 publication Critical patent/SK9649Y1/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/12—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity
    • C08L101/14—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity the macromolecular compounds being water soluble or water swellable, e.g. aqueous gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
SK50027-2022U 2019-09-06 2020-09-03 Hydrogél na báze zosieťovaného hydroxyfenylového derivátu kyseliny hyalurónovej SK9649Y1 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2019-36602U CZ33324U1 (cs) 2019-09-06 2019-09-06 Hydrogel na bázi zesíťovaného hydroxyfenylového derivátu kyseliny hyaluronové
CZPUV2019-36602 2019-09-06

Publications (2)

Publication Number Publication Date
SK500272022U1 SK500272022U1 (sk) 2022-07-27
SK9649Y1 true SK9649Y1 (sk) 2022-11-24

Family

ID=68384244

Family Applications (1)

Application Number Title Priority Date Filing Date
SK50027-2022U SK9649Y1 (sk) 2019-09-06 2020-09-03 Hydrogél na báze zosieťovaného hydroxyfenylového derivátu kyseliny hyalurónovej

Country Status (6)

Country Link
AT (1) AT18104U1 (cs)
CZ (1) CZ33324U1 (cs)
DE (1) DE212020000715U1 (cs)
FR (1) FR3104945B3 (cs)
SK (1) SK9649Y1 (cs)
WO (1) WO2021043349A1 (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ308970B6 (cs) * 2020-05-12 2021-10-27 Contipro A.S. Sada gelotvorných roztoků určená pro přípravu hydrogelu na bázi kovalentně zesítěného hydroxyfenylového derivátu hyaluronanu k prevenci pooperačních komplikací souvisejících s vytvořením kolorektální anastomózy a její použití

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555747B2 (en) 1983-08-09 1986-10-09 Cilco Inc. Chondroitin sulfate and sodium hyaluronate composition
US6051560A (en) 1986-06-26 2000-04-18 Nestle S.A. Chrondroitin sulfate/sodium hyaluronate composition
DE10156617A1 (de) 2001-11-17 2003-05-28 Biosphings Ag Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus
ATE525076T1 (de) 2002-10-16 2011-10-15 Arthrodynamic Technologies Animal Health Division Inc Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) * 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
WO2006010066A2 (en) 2004-07-09 2006-01-26 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
KR101091028B1 (ko) * 2009-07-02 2011-12-09 아주대학교산학협력단 체내 주입형 하이드로젤 및 이의 생의학적 용도
KR101161640B1 (ko) * 2009-08-25 2012-07-02 서울과학기술대학교 산학협력단 리포산이 결합된 화합물과 이의 제조방법
EP3067069B1 (en) * 2009-11-11 2023-07-26 Hy2Care B.V. Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers
CZ28434U1 (cs) * 2015-05-18 2015-07-07 Contipro Biotech S.R.O. Nanokompozit na bázi hydroxyfenylového derivátu kyseliny hyaluronové nebo jejísoli obsahující nanočástice fosforečnanu vápenatého

Also Published As

Publication number Publication date
CZ33324U1 (cs) 2019-10-25
AT18104U1 (de) 2024-02-15
FR3104945A3 (fr) 2021-06-25
SK500272022U1 (sk) 2022-07-27
DE212020000715U1 (de) 2022-04-21
WO2021043349A1 (en) 2021-03-11
FR3104945B3 (fr) 2021-12-10

Similar Documents

Publication Publication Date Title
US8481080B2 (en) Method of cross-linking hyaluronic acid with divinulsulfone
EP1753787B1 (en) Method of covalently linking hyaluronan and chitosan
JP5746617B2 (ja) キトサン混合物を形成する注入可能なヒドロゲル
RU2613887C2 (ru) Устойчивый к расщеплению сшитый низкомолекулярный гиалуронат
US20080031854A1 (en) Thiolated macromolecules and methods of making and using thereof
CZ20011650A3 (cs) Zesítěné hyaluronové kyseliny
US8202986B2 (en) Branched hyaluronic acid and method of manufacture
EP4038105B1 (en) A hyperbranched polyglycerol polyglycidyl ether and its use as crosslinker for polysaccharides
Fakhari Biomedical application of hyaluronic acid nanoparticles
SK9649Y1 (sk) Hydrogél na báze zosieťovaného hydroxyfenylového derivátu kyseliny hyalurónovej
JP2022550111A (ja) グルコン酸亜鉛およびヒアルロン酸エステルをベースとするヒドロゲル
Wei et al. Heparosan crosslinked hydrogels for injectable dermal fillers: fabrication, physicochemical properties and biocompatibility
EP3980029B1 (en) Means for use in preparation of hydrogel based on hydroxyphenyl derivative of hyaluronan, method of hydrogel preparation and use thereof
CN106714856B (zh) 含有糖胺聚糖和蛋白质的组合物
TWI728463B (zh) 基於硫酸化玻尿酸之水凝膠及含彼之藥學組成物
CZ33901U1 (cs) Prostředek pro použití k přípravě hydrogelu na bázi hydroxyfenylového derivátu hyaluronanu
RU2750000C1 (ru) Способ получения модифицированного гиалуронана и его применение в медицине, в том числе при эндопротезировании
CN113943382B (zh) 一种丙烯酸酯类修饰的透明质酸（钠）及其合成方法和应用
Trifan et al. Strategies of hyaluronan chemical modifications for biomedical applications
Kumar et al. Use of Polysaccharides: Novel Delivery System for Genetic Material
IT202100012737A1 (it) Miscele di polisaccaridi e poliamminosaccaridi con proprietà reologiche migliorate
Dhanasingh sP (EO-stat-PO)-glycosaminoglycans (GAGs) hybrid-hydrogels for medical applications
Noh Hyaluronan-based hydrogel scaffolds
Stern Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett